MusclePharm Corporation
OTC Bulletin Board : MSLP

November 15, 2010 13:00 ET

MusclePharm Corporation (MSLP) Retains Mina Mar Group and Mina Mar Marketing Group for MA and IR Services

DENVER, COLORADO--(Marketwire - Nov. 15, 2010) - MusclePharm Corporation (OTCBB:MSLP) (http://musclepharm.com/) is pleased to announce that the company has retained Mina Mar Group (www.minamargroup.com) to assist MSLP with mergers and acquisitions (MA), and Mina Mar Marketing Group (www.minamargroup.net) as the company's investor relations (IR) provider.

MusclePharm® Corporation is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB.

The Company's award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including www.bodybuilding.com, www.Amazon.com and www.Vitacost.com.

See more about the company @ www.musclepharm.com.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of MusclePharm Corporation that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. MusclePharm Corporation cautions you that any forward-looking information provided by or on behalf of MusclePharm Corporation is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. MusclePharm Corporation's actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond MusclePharm Corporation's control. In addition to those discussed in MusclePharm Corporation's press releases, public filings, and statements by MusclePharm Corporation's management, including, but not limited to, MusclePharm Corporation's estimate of the sufficiency of its existing capital resources, MusclePharm Corporation's ability to raise additional capital to fund future operations, MusclePharm Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match MusclePharm Corporation's capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. MusclePharm Corporation does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

Contact Information